Bebbington
Charles P. Bebbington, Doylestown, PA US
Patent application number | Description | Published |
---|---|---|
20110106294 | Automatic battery exchange system for mobile vehicles - A battery exchange system for a battery-powered mobile vehicle comprises an exchanger automatic guided vehicle (“EAGV”) which is controlled by a central computer and which comprises a linking member that is temporarily connectable to the battery and a motive member that moves the battery at least horizontally relative to the mobile vehicle. During a battery exchange operation, the EAGV automatically engages the battery and removes the battery from the mobile vehicle. The EAGV may then automatically engage a charged battery and insert the charged battery into the mobile vehicle. | 05-05-2011 |
20110113593 | Self reversing caster - A caster assembly includes a swivel assembly having a pivot axis, a housing which is connected to the swivel assembly, and a wheel which is slidably supported for linear movement along the longitudinal axis of the housing. The wheel is slidable along the longitudinal axis to move the rotational axis of the wheel from one side of the pivot axis to the other. | 05-19-2011 |
Conrad Bebbington, Slough GB
Patent application number | Description | Published |
---|---|---|
20140184731 | METHOD AND APPARATUS FOR MOTION BASED PARTICIPANT SWITCHING IN MULTIPOINT VIDEO CONFERENCES - In one embodiment, an apparatus comprises a memory that stores executable instructions and a processor that executes the instructions in order to determine, for plural received compressed video inputs, at least one motion vector included in each of the plural compressed video inputs; calculate, based on the determined motion vectors, a motion value corresponding to each of the plural compressed video inputs, the motion values representing a level of motion over several frames for each of the plural compressed video inputs; and select, based on the calculated motion values, at least one of the plural compressed video inputs to be displayed. | 07-03-2014 |
David Bebbington, Abingdon GB
Patent application number | Description | Published |
---|---|---|
20110086856 | COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. | 04-14-2011 |
David Bebbington, Newbury GB
Patent application number | Description | Published |
---|---|---|
20090312543 | PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - This invention describes novel pyrazole compounds of formula IIIa: | 12-17-2009 |
20120071657 | TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - This invention describes novel triazole compounds of formula IX: | 03-22-2012 |
20130096128 | PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - This invention describes novel pyrazole compounds of formula III: | 04-18-2013 |
20140187772 | PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - This invention describes novel pyrazole compounds of formula III: | 07-03-2014 |
David Bebbington, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20080287444 | PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - This invention describes novel pyrazole compounds of formula III: | 11-20-2008 |
David Bebbington, Pewsey GB
Patent application number | Description | Published |
---|---|---|
20110178069 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME - The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-γ-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-γ-mediated diseases and decreasing IGIF and IFN-γ production using the compounds and compositions of this invention. This invention also relates to methods for preparing N-acylamino compounds. | 07-21-2011 |
20120165319 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME - The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently, may be advantageously used as agents against IL-1-, apoptosis-, IGIF-, and IFN-γ-mediated diseases, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases. This invention also relates to methods for inhibiting ICE activity, for treating interleukin-1-, apoptosis-, IGIF- and IFN-γ-mediated diseases and decreasing IGIF and IFN-γ production using the compounds and compositions of this invention. This invention also relates to methods for preparing N-acylamino compounds. | 06-28-2012 |